These benefits, along with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 guidance the concept of targeting ACKR3 as a novel method to modulate the opioid system, which could open new therapeutic avenues for opioid-similar Diseases. These results propose that conolidine is https://richardw155ykv0.thekatyblog.com/profile